tiprankstipranks
Advertisement
Advertisement
Leerink starts ‘interesting preclinical-stage opportunity’ Atrium at Outperform
PremiumThe FlyLeerink starts ‘interesting preclinical-stage opportunity’ Atrium at Outperform
3M ago
Atrium Therapeutics initiated with an Outperform at Leerink
Premium
The Fly
Atrium Therapeutics initiated with an Outperform at Leerink
3M ago
Trump Trade: U.S. plans AI security order without required model tests
Premium
The Fly
Trump Trade: U.S. plans AI security order without required model tests
3M ago
Atrium Therapeutics  initiated with an Overweight at Wells Fargo
PremiumThe FlyAtrium Therapeutics initiated with an Overweight at Wells Fargo
5M ago
Controversial Prasad leaving FDA, NYT reports
Premium
The Fly
Controversial Prasad leaving FDA, NYT reports
5M ago
RNA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
RNA Earnings this Week: How Will it Perform?
5M ago
Why Is Avidity Biosciences Stock (RNA) Down Today?
PremiumMarket NewsWhy Is Avidity Biosciences Stock (RNA) Down Today?
6M ago
Avidity Shareholders Approve Novartis Merger and Spin-Off
Premium
Company Announcements
Avidity Shareholders Approve Novartis Merger and Spin-Off
6M ago
One new option listing and one option delisting on February 26th
Premium
The Fly
One new option listing and one option delisting on February 26th
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100